Featured Articles
Trending Articles
Breakthrough in First-Line Ovarian Cancer Treatment: KEYTRUDA and LYNPARZA
Clinical Trials | 10 December 2024
FDA Grants Accelerated Approval to Bizengri for Treating NRG1+ Pancreatic Cancer and NSCLC
FDA & EMA | 5 December 2024
Fixed-Duration Acalabrutinib Plus Venetoclax Achieves Superior 77% PFS in Untreated CLL
Clinical Trials | 9 December 2024
Adding Blinatumomab to Chemotherapy Extends 96% DF Survival in Pediatric Leukemia
Clinical Trials | 8 December 2024
AI-Driven Cancer Therapy: Recursion Doses First Patient in REC-1245 Trial for Solid Tumors
AI | 6 December 2024
Promising Sac-TMT Receives FDA Breakthrough Therapy Designation for Lung Cancer
FDA & EMA | 7 December 2024
Durvalumab Granted FDA Priority Review for Muscle-Invasive Bladder Cancer Patients
FDA & EMA | 7 December 2024
FDA Approves Durvalumab as the First and Only Immunotherapy for LSSC Lung Cancer
FDA & EMA | 5 December 2024
AI-Powered PET/CT Analysis May Predict Side Effects of Immunotherapy in Lung Cancer
AI | 29 November 2024
The FDA Approves IMKELDI, the First Oral Liquid Form of Imatinib, for Leukemia
FDA & EMA | 27 November 2024
Roche Acquires Poseida in $1.5 Billion Deal to Advance Cell Therapy Innovation
Pharma | 28 November 2024
SKYSCRAPER-01 Trial Shows Safety of Tiragolumab Plus Atezolizumab in Lung Cancer
Clinical Trials | 26 November 2024
FDA Greenlights Revumenib for Relapsed Leukemia Treatment
ONCOLife | 23 November 2024
How Oncolytic Viruses Could Be a New Frontier in Transforming Cancer Treatment
ONCOLife
20 November 2024
UK Researchers Launch Groundbreaking Study to Uncover Cancer Survival Secrets
ONCOLife
19 November 2024
FDA Approves MI Cancer Seek Test for Targeted Cancer Therapy
ONCOLife
9 November 2024
Role of CGP Testing in the Management of Cancer Treatment and Personalized Care
ONCOLife
4 November 2024
Transforming Melanoma Treatment with DNA Plasmid Vaccine
ONCOLife
28 October 2024
Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global
Webinar
31 October 2024
Targeting NBR1: New Biomarker Could Predict Immunotherapy Success in Liver Cancer
Biotech
20 October 2024
AI-Powered Cancer Drug LP-184 Receives FDA Fast-Track Designation for Glioblastoma
FDA & EMA
17 October 2024
FDA Approves VYLOY™ as a New Targeted Therapy for Advanced Gastric and GEJ Cancer
FDA & EMA
19 October 2024